Yu‐Yun Shao
Shanghai Medical College of Fudan University(CN)National Taiwan University of Science and Technology(TW)National Taiwan University(TW)PLA Information Engineering University(CN)Chinese Center For Disease Control and Prevention(CN)Chinese Academy of Medical Sciences & Peking Union Medical College(CN)Wuhan University(CN)National Taiwan University Hospital(TW)Beijing Children’s Hospital(CN)Affiliated Zhongshan Hospital of Dalian University(CN)Jiangsu Provincial Hospital of Traditional Chinese Medicine(CN)
Publications by Year
Research Areas
Hepatocellular Carcinoma Treatment and Prognosis, Cancer Mechanisms and Therapy, Colorectal Cancer Treatments and Studies, Cancer Immunotherapy and Biomarkers, Liver Disease Diagnosis and Treatment
Most-Cited Works
- → Early alpha‐fetoprotein response predicts treatment efficacy of antiangiogenic systemic therapy in patients with advanced hepatocellular carcinoma(2010)172 cited
- → Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma(2010)126 cited
- → Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan(2020)113 cited
- → Early alpha‐foetoprotein response associated with treatment efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma(2019)107 cited
- → High Serum Transforming Growth Factor-β1 Levels Predict Outcome in Hepatocellular Carcinoma Patients Treated with Sorafenib(2015)102 cited
- → Hepatitis B virus infection and the risk of cancer among the Chinese population